Gender-related differences in prolactin secretion in pituitary prolactinomas
- PMID: 12012125
- DOI: 10.1007/s00234-002-0774-2
Gender-related differences in prolactin secretion in pituitary prolactinomas
Abstract
In pituitary prolactinomas, serum prolactin (PRL) levels usually parallel the tumor size. We conducted a retrospective study to determine differences in PRL production between men and women with prolactinomas. A total of 51 patients, 16 men and 35 women, was studied. We investigated clinical, endocrinological, radiological and histological findings, and estimated the tumor volume (TV) by high-resolution magnetic resonance imaging (MRI). Correlation between PRL level and TV was low in men (R=0.458), in contrast to women (R=0.953), c. Men with prolactinomas showed predominance of large tumors (P=0.0009) with high PRL levels (P=0.0009) and had greater tendencies for cyst formation (P=0.0047). Large prolactinomas tended to be accompanied by cyst(s) (P=0.0051) and hemorrhage ( P=0.0015), both of which were associated with reduced PRL secretion (P=0.0004 and P<0.0001, respectively). When the volume of the cysts and hemorrhage was subtracted from the total TV, correlation between PRL level and TV became greater (R=0.905) with no gender difference. Histological examination demonstrated a sparsely granulated type of lactotroph adenoma with occasional fibrosis, particularly in tumors with hemorrhage and cysts. Although a significant discrepancy between PRL level and TV may exist in prolactinomas when intratumoral hemorrhage and/or cysts are present, there is no essential difference in PRL secretion between the sexes.
Similar articles
-
Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.Cancer. 2002 Jul 15;95(2):258-66. doi: 10.1002/cncr.10676. Cancer. 2002. PMID: 12124824
-
Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.Acta Neurochir (Wien). 2005 Jul;147(7):751-7; discussion 757-8. doi: 10.1007/s00701-005-0498-2. Epub 2005 Mar 14. Acta Neurochir (Wien). 2005. PMID: 15971099
-
[Prolactinoma in man: clinical and histological characteristics].Ann Endocrinol (Paris). 2000 Sep;61(3):253-7. Ann Endocrinol (Paris). 2000. PMID: 10970951 French.
-
[Invasive giant prolactinoma].Acta Otorrinolaringol Esp. 1998 Mar;49(2):156-8. Acta Otorrinolaringol Esp. 1998. PMID: 9650316 Review. Spanish.
-
[Prolactin producing adenoma].Nihon Rinsho. 1993 Oct;51(10):2685-90. Nihon Rinsho. 1993. PMID: 8254940 Review. Japanese.
Cited by
-
Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment.Front Endocrinol (Lausanne). 2024 Feb 2;15:1338345. doi: 10.3389/fendo.2024.1338345. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38370355 Free PMC article. Review.
-
Cabergoline-induced fibrosis of prolactinomas: a neurosurgical perspective.BMJ Case Rep. 2017 Nov 3;2017:bcr2017220971. doi: 10.1136/bcr-2017-220971. BMJ Case Rep. 2017. PMID: 29102970 Free PMC article.
-
Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery.Front Endocrinol (Lausanne). 2020 Jul 7;11:439. doi: 10.3389/fendo.2020.00439. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32733387 Free PMC article.
-
Effect of dopaminergic drug treatment on surgical findings in prolactinomas.Pituitary. 2011 Mar;14(1):68-74. doi: 10.1007/s11102-010-0261-4. Pituitary. 2011. PMID: 20878243 Free PMC article.
-
Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference.Neuroradiology. 2015 Jul;57(7):679-84. doi: 10.1007/s00234-015-1519-3. Epub 2015 Apr 7. Neuroradiology. 2015. PMID: 25845810
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical